← AlphaSignal

Notes

Top 5 Undervalued US Common Stocks with Improving Fundamentals (September 19, 2026)

2026-09-19Screening report

Data as of 2026-09-19US market

Summary

Screened 12 undervalued US stocks on September 19, 2026; ADBE, PYPL, LEN, CVS, and ADSK offer the strongest fundamental resilience, margin expansion, and valuation discounts for a 6 to 18 month horizon.

Screening weights

Fundamental improvement30%
Valuation25%
Balance sheet15%
Catalysts15%
Price dislocation10%
Risk5%

Candidate comparison

RankTickerSector3M returnRevenue YoYOPM ΔFCFScore
1
Adobe Inc.
Software-18.2%+10.6%+1.5%pPositive9.3
2
PayPal Holdings
Fintech-10.4%+8.2%+1.1%pPositive9.1
3
Lennar Corporation
Homebuilding-15.8%+7.9%+0.2%pPositive8.9
4
CVS Health
Healthcare-6.5%+7.3%+1.0%pPositive8.7
5
Autodesk
Design Software-4.8%+16.0%+2.0%pPositive8.5
6
Western Digital
Storage Hardware-7.8%+23.8%+4.3%pPositive8.4
7
Lululemon Athletica
Consumer-21.4%+7.3%+0.4%pPositive8.2
8
NIKE
Consumer-16.7%+1.2%+0.5%pPositive8.0
9
Salesforce
Cloud CRM-13.7%+8.4%+3.2%pPositive7.9
10
J.B. Hunt Transport
Industrials-14.6%+4.8%+0.3%pPositive7.8
11
Starbucks
Restaurants-4.8%+2.2%+0.4%pPositive7.5
12
Intel
Semiconductors-15.0%+7.5%+0.6%pPositive6.6

Screened names (observations)

ADBEAdobe Inc.

Score: 9.3

Open ticker →

Observation

Extreme cash-flow dislocation at $245-$250 multi-year low with daily RSI at 21.05. Despite cautious guidance, Q3 revenue expanded +10.6% YoY generating over $2.2B in quarterly FCF ($8B+ annual run-rate). Trading at ~9.5x trailing FCF with $2.23B quarterly buybacks retiring 29M shares YoY.

Catalysts to watch

  • Oversold technical mean-reversion toward 20-day moving average
  • Commercial Firefly and GenStudio enterprise contracts scaling
  • Aggressive multi-billion dollar open-market share repurchases

Risks

  • Generative AI design pricing competition
  • Elongation in creative agency enterprise sales cycles

Framework exit signals

  • Digital Media net new ARR growth falls below +8% YoY
  • GAAP operating margin contracts below 32%

Metrics to watch

  • Digital Media net new ARR
  • Enterprise GenStudio adoption count

PYPLPayPal Holdings

Score: 9.1

Open ticker →

Observation

Trading at ~12.5x Forward P/E despite sustained operational turnaround: TMD growth +8.2% YoY, Fastlane checkout lifting conversions by 80%, and $5B+ in buybacks retiring >7% of the float annually.

Catalysts to watch

  • Fastlane enterprise scaling across Shopify and global merchants
  • Venmo monetization via debit and merchant pay
  • Accelerating EPS accretion from aggressive share retirement

Risks

  • Competition from Stripe and Apple Pay
  • Macro e-commerce consumer spending softness

Framework exit signals

  • TMD dollar growth turns negative YoY
  • Non-GAAP OPM falls below 16.5%

Metrics to watch

  • TMD growth YoY
  • Active accounts transaction volume

LENLennar Corporation

Score: 8.9

Open ticker →

Observation

Compelling valuation dislocation at ~9.5x P/E with zero net homebuilding debt and $3.5B+ cash reserves following Q3 earnings pullback. Structural chronic US housing shortages and disciplined land-light operational execution provide deep asymmetric margin of safety.

Catalysts to watch

  • Easing Treasury yields following post-FOMC stabilization
  • Consistent $250M quarterly share repurchase program
  • Resilient order backlogs supported by targeted rate buydowns

Risks

  • Stubborn mortgage rates delaying buyer contract closing
  • Incentive cost pressure on gross margins

Framework exit signals

  • Homebuilding gross margin drops below 20.0%
  • Quarterly net deliveries fall >10% YoY

Metrics to watch

  • Homebuilding gross margin
  • Quarterly new orders count

CVSCVS Health

Score: 8.7

Open ticker →

Observation

Deep value turnaround trading at ~11.2x forward P/E with a 2.9% dividend yield. Q2 Medical Benefit Ratio improved 250 bps YoY to 87.4%, operational restructuring is on schedule, and full-year CFFO is reaffirmed at $11.5B+.

Catalysts to watch

  • Multi-year Medicare Advantage margin recovery pathway
  • Aetna Claims Assist AI operational cost efficiencies
  • MinuteClinic and care delivery volume expansion

Risks

  • Second-half medical cost utilization spikes
  • PBM regulatory scrutiny

Framework exit signals

  • MBR exceeds 89.5% for two consecutive quarters
  • Operating margins compress >100 bps YoY

Metrics to watch

  • Health Care Benefits MBR
  • Annual operating cash flows

ADSKAutodesk

Score: 8.5

Open ticker →

Observation

High-barrier AEC software monopoly with 90%+ gross margins and 41% Non-GAAP operating margins. Trading at ~20.5x forward P/E, a 25% discount to its 5-year historical average, with global rollout of its direct agency model completed.

Catalysts to watch

  • Direct agency New Transaction Model driving multi-quarter margin expansion
  • Generative AI design assistant monetization across Forma and Fusion
  • MaintainX operational workflow cross-selling

Risks

  • Sales cycle elongation during new model transition
  • Commercial construction macro softness

Framework exit signals

  • Billings growth falls below +5.0% YoY
  • cRPO growth drops below 6.0% YoY

Metrics to watch

  • cRPO constant-currency growth rate
  • Free cash flow conversion

Sources

AlphaSignal Research: Top 5 Undervalued US Common Stocks (Sep 19, 2026)

1. Executive Summary

Following the September 18 Triple Witching expiration and post-FOMC yield adjustments, institutional capital rotation has highlighted exceptional valuation discounts among cash-generative US market leaders. By screening 12 US common stocks characterized by lagging 3-month price returns despite expanding quarterly operating profitability, steady revenue growth, and robust free cash flow, we finalized the Top 5 Undervalued US Stocks offering asymmetric risk/reward over a 6 to 18 month horizon.

2. Candidate Comparison Table

  1. ADBE (Score: 9.3) | Software | 3M Return: -18.2% | Rev Growth: +10.6% | OPM Change: +1.5%p | FCF: Positive
  2. PYPL (Score: 9.1) | FinTech | 3M Return: -10.4% | Rev Growth: +8.2% | OPM Change: +1.1%p | FCF: Positive
  3. LEN (Score: 8.9) | Homebuilding | 3M Return: -15.8% | Rev Growth: +7.9% | OPM Change: +0.2%p | FCF: Positive
  4. CVS (Score: 8.7) | Healthcare | 3M Return: -6.5% | Rev Growth: +7.3% | OPM Change: +1.0%p | FCF: Positive
  5. ADSK (Score: 8.5) | Design Software | 3M Return: -4.8% | Rev Growth: +16.0% | OPM Change: +2.0%p | FCF: Positive
  6. WDC (Score: 8.4) | 7. LULU (Score: 8.2) | 8. NKE (Score: 8.0) | 9. CRM (Score: 7.9) | 10. JBHT (Score: 7.8) | 11. SBUX (Score: 7.5) | 12. INTC (Score: 6.6)

3. Top 5 Detailed Breakdown

  • ADBE (9.3): Multi-year low ($245-$250, RSI 21) creating extreme cash-flow dislocation at ~9.5x trailing FCF ($8B+ annual run-rate); Q3 revenue +10.6% YoY with $2.23B quarterly buybacks retiring 29M shares YoY.
  • PYPL (9.1): P/E ~12.5x, TMD +8.2% YoY turnaround, Fastlane conversion lift 80%, retiring >7% of shares annually via $5B+ repurchases.
  • LEN (8.9): P/E ~9.5x with zero net homebuilding debt and $3.5B+ cash reserves; secular US housing shortage and land-light execution provide strong downside floor.
  • CVS (8.7): P/E ~11.2x, 2.9% dividend yield, Q2 MBR improved 250 bps YoY to 87.4%, CFFO guidance reaffirmed at $11.5B+.
  • ADSK (8.5): P/E ~20.5x (25% historical discount), 90%+ gross margins, 41% Non-GAAP OPM, direct agency model transition complete.

4. Conclusion

  • Highest Conviction: ADBE
  • Best Cash-Flow Compounder: PYPL
  • Best Balance Sheet & Value: LEN
  • Best Turnaround: CVS
  • Most Defensive Moat: ADSK
  • Watchlist: WDC, LULU, NKE, CRM

Not investment advice. Scores and lists are relative snapshots.

← All notes